Genetic Signatures Limited (GSS.AX)

AUD 0.63

(-8.03%)

EBITDA Summary of Genetic Signatures Limited

  • Genetic Signatures Limited's latest annual EBITDA in 2024 was -20.33 Million AUD , down -54.8% from previous year.
  • Genetic Signatures Limited's latest quarterly EBITDA in 2024 FY was N/A , down -16.45% from previous quarter.
  • Genetic Signatures Limited reported an annual EBITDA of -13.13 Million AUD in 2023, down -478.9% from previous year.
  • Genetic Signatures Limited reported an annual EBITDA of 4.69 Million AUD in 2022, up 53.69% from previous year.
  • Genetic Signatures Limited reported a quarterly EBITDA of -11.31 Million AUD for 2024 Q2, down 0.0% from previous quarter.
  • Genetic Signatures Limited reported a quarterly EBITDA of -9.01 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Genetic Signatures Limited (2024 - 2013)

Historical Annual EBITDA of Genetic Signatures Limited (2024 - 2013)

Year EBITDA EBITDA Growth
2024 -20.33 Million AUD -54.8%
2023 -13.13 Million AUD -478.9%
2022 4.69 Million AUD 53.69%
2021 3.21 Million AUD 175.55%
2020 -1.69 Million AUD -26.18%
2019 -3.12 Million AUD -13.07%
2018 -2.76 Million AUD -20.05%
2017 -2.3 Million AUD 11.32%
2016 -2.59 Million AUD -5.93%
2015 -2.37 Million AUD -116.9%
2014 -2.23 Million AUD 48.71%
2013 -2.2 Million AUD 0.0%

Peer EBITDA Comparison of Genetic Signatures Limited

Name EBITDA EBITDA Difference
Australian Clinical Labs Limited 181.83 Million AUD 111.185%
BCAL Diagnostics Limited -5.66 Million AUD -258.897%
Genetic Technologies Limited -11.43 Million AUD -77.924%
Healius Limited -298.09 Million AUD 93.177%
Imagion Biosystems Limited -13.69 Million AUD -48.487%
Integral Diagnostics Limited 12.33 Million AUD 264.894%
INOVIQ Ltd -6.63 Million AUD -206.601%
Microba Life Sciences Limited -22.8 Million AUD 10.833%
Monash IVF Group Limited 13.02 Million AUD 256.146%
Rhythm Biosciences Limited -6.79 Million AUD -199.269%
Sonic Healthcare Limited 1.65 Billion AUD 101.226%